New Results
Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases
Nicholas G Reich, Justin Lessler, Jay K Varma, Neil M Vora
doi: https://doi.org/10.1101/156497
Nicholas G Reich
1University of Massachusetts, Amherst, Massachusetts, USA
Justin Lessler
2Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
Jay K Varma
3New York City Department of Health and Mental Hygiene, USA
4Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Neil M Vora
3New York City Department of Health and Mental Hygiene, USA
4Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Article usage
Posted June 28, 2017.
Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases
Nicholas G Reich, Justin Lessler, Jay K Varma, Neil M Vora
bioRxiv 156497; doi: https://doi.org/10.1101/156497
Subject Area
Subject Areas
- Biochemistry (7315)
- Bioengineering (5292)
- Bioinformatics (20185)
- Biophysics (9970)
- Cancer Biology (7696)
- Cell Biology (11242)
- Clinical Trials (138)
- Developmental Biology (6415)
- Ecology (9910)
- Epidemiology (2065)
- Evolutionary Biology (13268)
- Genetics (9347)
- Genomics (12542)
- Immunology (7666)
- Microbiology (18923)
- Molecular Biology (7414)
- Neuroscience (40858)
- Paleontology (298)
- Pathology (1224)
- Pharmacology and Toxicology (2124)
- Physiology (3137)
- Plant Biology (6834)
- Synthetic Biology (1890)
- Systems Biology (5295)
- Zoology (1083)